Fawzia Bardag to Proteasome Inhibitors
This is a "connection" page, showing publications Fawzia Bardag has written about Proteasome Inhibitors.
Connection Strength
2.186
-
Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis. Exp Mol Pathol. 2012 Aug; 93(1):26-34.
Score: 0.383
-
Proteasome inhibitor treatment in alcoholic liver disease. World J Gastroenterol. 2011 May 28; 17(20):2558-62.
Score: 0.362
-
Proteasome inhibitor up regulates liver antioxidative enzymes in rat model of alcoholic liver disease. Exp Mol Pathol. 2011 Feb; 90(1):123-30.
Score: 0.348
-
Epigenetics of proteasome inhibition in the liver of rats fed ethanol chronically. World J Gastroenterol. 2009 Feb 14; 15(6):705-12.
Score: 0.309
-
CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp Mol Pathol. 2006 Dec; 81(3):191-201.
Score: 0.263
-
Modifications in P62 occur due to proteasome inhibition in alcoholic liver disease. Life Sci. 2005 Sep 30; 77(20):2594-602.
Score: 0.245
-
Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury. Exp Mol Pathol. 2013 Apr; 94(2):352-9.
Score: 0.101
-
The use of a reversible proteasome inhibitor in a model of Reduced-Size Orthotopic Liver transplantation in rats. Exp Mol Pathol. 2012 Aug; 93(1):99-110.
Score: 0.096
-
Nuclear effects of ethanol-induced proteasome inhibition in liver cells. World J Gastroenterol. 2009 Mar 14; 15(10):1163-7.
Score: 0.078